Abstract:Molecular properties and dynamic interaction of enantiomeric propranolol/beta‐cyclodextrin are studied through comprehensive molecular dynamic simulations. The simulations provide insights into the properties such as tability, flexibility and intermolecular interaction of these inclusion complexes, elucidating the preferential binding modes and stability of each enantiomer within the cyclodextrin cavity. Capture of the time‐dependent progress of molecular interactions reveals the dynamic nature of the host‐guest system. This study enchances the understanding of enantiomeric recognition processes, with implications for drug delivery and chiral separation strategies. The graphical abstract visually encapsulates these dynamic interactions, illustrating the intricate interplay between enantiomeric propranolol and beta‐cyclodextrin, prividing a comprehensive overview of the simulation findings. In this study, the enantioselectivity of β‐cyclodextrin and its derivatives towards propranolol enantiomers are investigated by molecular dynamic (MD) simulations. β‐cyclodextrin (β‐CD) have previously been shown to be able to recognize propranolol (PRP) enantiomers. To improve upon the enantioselectivity of β‐cyclodextrin, we propose the use of an ionic‐liquid‐modified‐β‐cyclodextrin (β‐CD‐IL). β‐CD‐IL was found to be able to complex R and S propranolol enantiomers with differing binding energies. The molecular docking study reveals that the ionic liquid chain attached to the β‐CD molecule has significant interaction with propranolol. The formation of the most stable complex occurred between (S)‐β‐CD‐IL and (S)‐propranolol with an energy of −5.80 kcal/mol. This is attributed to the formation of a hydrogen bond between the oxygen of the propranolol and the hydrogen on the primary rim of the (S)‐β‐CD‐IL cavity. This interaction is not detected in other complexes. The root mean‐squared fluctuation (RMSF) value indicates that the NH group is the most flexible molecular fragment, followed by the aromatic group. Also of note, the formation of a complex between pristine β‐CD and (S)‐propranolol is the least favorable.

Enantioselective binding to the human organic cation transporter-1 (hOCT1) determined using an immobilized hOCT1 liquid chromatographic stationary phase

[Stereoselective Determination of Propranolol Enantiomer in Transgenic Cell Lines Expressing Human Cytochrome P450].

Determination of the Enantioselectivity of Six Chiral Aryloxy Aminopropanol Drugs Transport Across Caco-2 Cell Monolayers

CHIRAL RP-HPLC ASSAY FOR PROPAFENONE ENANTIOMERS IN RAT LIVER MICROSOMAL INCUBATES AND ITS APPLICATION IN VITRO METABOLISM

Enantioseparation and Determination of Propranolol in Human Plasma on a New Derivatized Β-Cyclodextrin Bonded Phase by HPLC

[Enatiomeric Separation of Beta-Blocking Agents and Analogs]

Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers.

G-protein-coupled Receptor Chromatographic Stationary Phases. 2. Ligand-induced Conformational Mobility in an Immobilized Beta2-Adrenergic Receptor.

Study on the stereoselectivity of racemic propranolol glucuronidation metabolism

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY SEPARATION AND QUANTITATION OF PROPRANOLOL GLUCURONIDE IN RAT MICROSOMES

An enantioselective study of β‐cyclodextrin and ionic liquid‐β‐cyclodextrin towards propranolol enantiomers by molecular dynamic simulations

Enantioselective transport of l-propranolol through a bulk liquid membrane containing complex of (S, S)-di-n-dodecyltartrate and boric acid

Enantiomeric Separation of Β-Blockers by HPLC Using (R)-1-naphthylglycine and 3,5-Dinitrobenzoic Acid As Chiral Stationary Phase

Stereoselective accumulation of propranolol enantiomers in K562 and K562/ADR cells.

[Enantioseparation and Determination of Atenolol Enantiomers in Tables on a Β-Cyclodextrin-based Chiral Stationary Phase by High Performance Liquid Chromatography].

Study on the Interaction Between the Chiral Drug of Propranolol and Α1-Acid Glycoprotein by Fluorescence Spectrophotometry

In vitro enantioselective metabolism of TJ0711 hydrochloride by human liver microsomes using a novel chiral liquid chromatography-tandem mass spectrometry method.

Enantioselective Separation of Propranolol Enantiomers by Chiral Extraction

Stereoselectivity and Interaction Between the Glucuronidation of S-(-)- and R-(+)-Propranolol in Rat Hepatic Microsomes Pretreated with Different Inducers

Reversed-phase High-Performance Liquid Chromatographic Analysis of Atenolol Enantiomers in Rat Hepatic Microsome after Chiral Derivatization with 2,3,4,6-Tetra-o-acetyl-β-d-glycopyranosyl Isothiocyanate

Direct Determination of S-(-)- and R-(+)-propranolol Glucuronide in Rat Hepatic Microsomes by RP-HPLC.